Lunit, a Korean AI company specializing in medical imaging and diagnostics, said it has partnered with the Society for Immunotherapy of Cancer (SITC) to offer its AI-powered biomarker discovery platform to SITC-affiliated researchers. The...

Deep Bio utilizes deep learning-based algorithms to differentiate breast cancer lesions accurately, optimizing diagnostic accuracy SEOUL, SOUTH KOREA, May 21, 2024 /EINPresswire.com/ -- Deep Bio today announced the publication of a study...

South Korean biotech company GC Cell Corp. said Thursday that it signed a joint research and supply agreement with medical artificial intelligence (AI) company Lunit Inc. for new drug candidate AB-201. Under the agreement, GC Cell will conduct...

SEOUL, South Korea, Oct. 4, 2023 /PRNewswire/ -- Deep Bio, a leader in artificial intelligence (AI)-powered cancer diagnostics, announced today that it has been named to the Korea AI Startup 100 list. This prestigious list, representing a...

Philips Korea said on Tuesday that it installed its digital pathology solution at Konyang University Hospital, making the hospital the first university hospital in the central part of Korea equipped with a full digital pathology...

DeepBio said that its deep learning-based prostate cancer pathology diagnosis technology using a Gleason grading system acquired NET (new excellent technology) certification on Tuesday. NET certification is a certification system implemented...